CSIMarket
 


Soliton Inc   (SOLY)
Other Ticker:  
 

Soliton Inc 's Working Capital Ratio

SOLY's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth


Soliton Inc 's Current Assets grew by 4.54 % in the III Quarter 2021 sequentially, while Current Liabilities decreased, this led to improvement in Soliton Inc 's Working Capital Ratio to 5.47, Working Capital Ratio remained below Soliton Inc average.

Within Medical Equipment & Supplies industry 90 other companies have achieved higher Working Capital Ratio than Soliton Inc in third quarter 2021. While Working Capital Ratio total ranking has improved so far during the III Quarter 2021 to 1477, from total ranking in the second quarter 2021 at 1561.

Explain Working Capital Ratio
How much in Current Assets SOLY´s has?
What is the value of SOLY´s Current Liabilities?


SOLY Working Capital Ratio (Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
III. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Current Liabilities Change 79.19 % 152.95 % 51.53 % -1.51 % -14.23 %
Y / Y Current Assets Change -35.06 % -42.28 % 218.56 % 164.94 % 297.51 %
Working Capital Ratio MRQ 5.47 5.09 9.84 11.44 15.1
SOLY's Total Ranking # 1477 # 1561 # 887 # 401 # 334
Seq. Current Liabilities Change -2.8 % 54.23 % -0.6 % 20.26 % 37.21 %
Seq. Current Assets Change 4.54 % -20.25 % -14.48 % -8.91 % -7.09 %



Working Capital Ratio third quarter 2021 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 91
Healthcare Sector # 616
Overall Market # 1477


Working Capital Ratio Statistics
High Average Low
22.3 6.93 0.01
(Jun 30 2020)   (Dec 31 2018)




Financial Statements
Soliton Inc 's Current Liabilities $ 4 Millions Visit SOLY's Balance sheet
Soliton Inc 's Current Assets $ 23 Millions Visit SOLY's Balance sheet
Source of SOLY's Sales Visit SOLY's Sales by Geography


Cumulative Soliton Inc 's Working Capital Ratio

SOLY's Working Capital Ratio for the trailling 12 Months

SOLY Working Capital Ratio

(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
III. Quarter
(Dec 31 2020)
IV. Quarter
(Sep 30 2020)
III. Quarter
Y / Y Current Liabilities TTM Growth 79.19 % 152.95 % 51.53 % -1.51 % -14.23 %
Y / Y Current Assets TTM Growth -35.06 % -42.28 % 218.56 % 164.94 % 297.51 %
Working Capital Ratio TTM 7.41 9.54 13.78 13.12 10.76
Total Ranking TTM # 4785 # 617 # 615 # 615 # 4487
Seq. Current Liabilities TTM Growth -2.8 % 54.23 % -0.6 % 20.26 % 37.21 %
Seq. Current Assets TTM Growth 4.54 % -20.25 % -14.48 % -8.91 % -7.09 %


On the trailing twelve months basis Due to decrease in Current Liabilities in the III Quarter 2021 to $4.20 millions, cumulative Working Capital Ratio decreased to 7.41 above the SOLY average Working Capital Ratio.
Working Capital Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 212 other companies have achieved higher Working Capital Ratio than Soliton Inc . While Working Capital Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2021 from 617 to 4785.

Explain Working Capital Ratio
How much in Current Assets SOLY´s has?
What is the value of SOLY´s Current Liabilities?

TTM Working Capital Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 213
Healthcare Sector # 987
Within the Market # 4785


trailing twelve months Working Capital Ratio Statistics
High Average Low
13.78 6.61 0.4
(Mar 31 2021)   (Jun 30 2019)




Companies with similar Working Capital Ratio in the quarter ending Sep 30 2021, within Medical Equipment & Supplies Industry Working Capital RatioSep 30 2021 MRQ Current AssetsSep 30 2021 MRQ Current Liabilities
Neurometrix Inc   14.72 $ 25.560  Millions$ 1.737  Millions
Movano Inc   14.70 $ 41.014  Millions$ 2.790  Millions
Predictive Oncology Inc   14.41 $ 43.040  Millions$ 2.986  Millions
Asensus Surgical Inc   14.31 $ 134.807  Millions$ 9.421  Millions
Clearpoint Neuro Inc   14.17 $ 64.995  Millions$ 4.588  Millions
Avita Medical Inc   13.77 $ 97.130  Millions$ 7.053  Millions
Orchestra Biomed Holdings Inc   13.63 $ 1.864  Millions$ 0.137  Millions
Invivo Therapeutics Holdings Corp   13.16 $ 21.391  Millions$ 1.626  Millions
Si bone inc   12.75 $ 185.648  Millions$ 14.564  Millions
Inmode Ltd   12.36 $ 470.114  Millions$ 38.045  Millions
Genedx Holdings Corp   12.10 $ 538.511  Millions$ 44.504  Millions
Axonics Inc   11.90 $ 330.229  Millions$ 27.751  Millions
Privia Health Group Inc   11.72 $ 469.424  Millions$ 40.046  Millions
Iradimed Corporation  11.33 $ 71.589  Millions$ 6.320  Millions
Neovasc Inc   11.08 $ 55.218  Millions$ 4.982  Millions
Inspiremd Inc   10.78 $ 40.091  Millions$ 3.720  Millions
Outset Medical Inc   10.46 $ 433.301  Millions$ 41.405  Millions
Conformis inc   10.28 $ 137.953  Millions$ 13.419  Millions
Pulmonx Corporation  10.25 $ 227.644  Millions$ 22.217  Millions
Alphatec Holdings Inc   10.04 $ 357.162  Millions$ 35.557  Millions
Endra Life Sciences Inc   9.99 $ 14.470  Millions$ 1.449  Millions
Assure Holdings Corp   9.98 $ 29.589  Millions$ 2.964  Millions
Abiomed Inc   9.69 $ 871.487  Millions$ 89.944  Millions
Inovio Pharmaceuticals Inc   9.49 $ 487.397  Millions$ 51.376  Millions
Carmell Corporation  9.47 $ 1.133  Millions$ 0.120  Millions
Motus Gi Holdings Inc   9.40 $ 24.878  Millions$ 2.646  Millions
Nephros Inc   9.35 $ 13.621  Millions$ 1.457  Millions
Atrion Corporation  9.03 $ 133.766  Millions$ 14.816  Millions
Lakeland Industries Inc   9.00 $ 124.889  Millions$ 13.872  Millions
Zynex inc   9.00 $ 69.858  Millions$ 7.761  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com